ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 25

SLE Flares Are Characterized By Generalized Polyclonal Expansions Of Antibody Secreting Cells Without Preference For Autoimmune Responses

H. Travis Ichikawa, Medicine, Emory University, Atlanta, GA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantibodies and plasma cells, B cell memory, Disease Activity, SLE

  • Tweet
  • Email
  • Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Increased circulating antibody secreting cells (ASC), including both CD138- plasmablasts and CD138+ plasma cells (PB/PC), correlate with SLE activity and are prominent during Lupus flares.   We tested whether this expansion is predominantly driven by typical SLE autoreactivities including anti-dsDNA, -Sm and -Ro and 9G4+ antibodies.    

Methods:

Peripheral blood lymphocytes (PBL) were collected from SLE patients (n=12; 4 mild-severe flare patients defined by SELENA-SLEDAI) with high serum levels of ≥1 autoantibody (anti-dsDNA, anti-Sm or anti-Ro).  PB/PC frequency was calculated as % of total B-cells by flow cytometry.  Anti-dsDNA, anti-Sm and anti-Ro60, 9G4+ and anti-microbial (anti-tetanus toxoid and anti-influenza) IgG ASC were detected by ELISPOT and expressed as % of total IgG ASC.   Memory cells were activated by stimulation with R848 and IL-2 for 7 days. Frequencies of antigen specific IgG memory cells were determined by ELISPOT as before. 

Results:

PB/PC frequencies were increased for up to 25-fold in SLE compared to HC and comprised up to 38 % of total B-cells.  Of total IgG ASC, frequencies of each SLE specific IgG ASC responses (anti-dsDNA, anti-Sm and anti-Ro60) never exceeded 3.4% (mean ± SD, 0.25 ± 0.65%) in patients with high serum antibody levels.   9G4+ ASC, which include several SLE-specific autoreactivities including anti-dsDNA and anti-apoptotic cells, were the most abundant autoreactivity but did not exceed 6% (mean ± SD, 2.2  ± 1.7%).  Combined, all the lupus–related autoreactivities accounted for <10% of all IgG ASC.   No correlation was found between PB/PC frequencies and SLE specific or 9G4+ IgG ASC frequencies.  Furthermore, anti-Tetanus and/or anti-influenza ASC, usually not found in healthy PBL, were found in SLE PBL in frequency similar to autoreactive responses (0.06 ± 0.09% and 0.37 ± 0.12%, respectively).   Anti-Sm, anti-Ro and 9G4 as well as anti-tetanus and anti-influenza reactive IgG memory cells were present in frequencies typically higher than that found for ASC of the same antigenic reactivity.  Notably, in 5 out of 6 patients with high anti-Ro serum titers, anti-Ro IgG memory cells represented > 2% of all IgG memory cells.  In contrast, anti-dsDNA IgG memory cell frequencies (0.01 ± 0.02%) were as low as anti-tetanus memory cell frequencies (0.12 ± 0.31%).

Conclusion:

Combined, conventional lupus autoreactivities only account for <10% of the greatly expanded numbers of circulating ASC characteristic of lupus flares.  In addition, these frequencies are lower than the frequency of memory cells for the corresponding autoantigens.  Moreover, antimicrobial responses are present in circulating ASC with frequencies similar to autoimmune responses.  While our studies did not test for other potential SLE autoreactivities, our results are consistent with a polyclonal expansion of ASC during lupus flares that is not predominantly driven by conventional autoantigens even in patients with high titers of serum antibodies.  These studies have important implications for our understanding of the mechanisms underlying lupus flares and the contribution of different cellular compartments to the generation of serum autoantibodies at different times in the course of the disease.


Disclosure:

H. T. Ichikawa,
None;

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sle-flares-are-characterized-by-generalized-polyclonal-expansions-of-antibody-secreting-cells-without-preference-for-autoimmune-responses/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology